DexCom stock reports 13.1 percent revenue growth at USD 86.62

{
  "signal_id": "1ed0f48c-1333-1091-27db-68de8519032b",
  "signal_type": "news",
  "signal_subtype": "has_earnings",
  "detected_at": "2026-09-28T11:55:08+00:00",
  "company": {
    "name": "Dexcom",
    "domain": "dexcom.com"
  },
  "data": {
    "url": "https://www.ad-hoc-news.de/boerse/news/corporate-news/dexcom-stock-reports-13-1-percent-revenue-growth-at-usd-86-62/70192686",
    "title": "DexCom stock reports 13.1 percent revenue growth at USD 86.62 - AD HOC NEWS",
    "excerpt": "DexCom stock (ISIN US2521311074) closed at USD 86.62 on Nasdaq on September 25, 2026, down 0.97 percent from the prior close. The latest quarterly report showed revenue of USD 1.31 billion, up 13.1 percent year over year, keeping operating growth at the center of the valuation debate. According to MarketBeat on September 25, 2026, DexCom reported USD 0.70 adjusted EPS for the quarter, above the USD 0.61 consensus estimate. Revenue reached USD 1.31 billion against expectations of USD 1.29 billion, a USD 0.02 billion beat that reinforces the importance of execution as the company expands continuous glucose monitoring adoption. DexCom develops real-time continuous glucose monitoring systems, including the Dexcom G7 and Stelo products. The business combines wearable sensors, software and data services, giving revenue growth a direct link to sensor adoption and recurring replacement demand. Yahoo Finance reported on September 17, 2026, that Truist Securities raised its DexCom price target from USD 93.00 to USD 102.00 while maintaining a Buy rating. The new target stands 17.72 percent above the September 25 closing price, while the average target listed by Investing.com was USD 94.48 on September 28, 2026. The comparison also shows why the stock's next move depends on more than the latest earnings beat. DexCom delivered double-digit revenue growth, but the September 25 close...",
    "summary": "DexCom reported adjusted earnings per share of USD 0.70 for the latest quarter, beating the consensus estimate of USD 0.61.",
    "planning": false,
    "image_url": "https://mdb.ad-hoc-news.de/bild/bild-2697605_1920_1080.webp",
    "confidence": 0.9,
    "published_at": "2026-09-28T11:55:08Z",
    "effective_date": "2026-09-25",
    "article_sentence": "According to MarketBeat on September 25, 2026, DexCom reported USD 0.70 adjusted EPS for the quarter, above the USD 0.61 consensus estimate."
  }
}

curl https://signals.autobound.ai/v1/signals/1ed0f48c-1333-1091-27db-68de8519032b \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"dexcom.com","limit":20}'